|
to-BBB is a Dutch biotechnology company in the field of brain-targeted drug delivery which uses its platform technologies to synergize with established and marketed drugs.
to-BBB’s vision is that the treatment of currently unserved brain diseases will be best achieved by targeting to endogenous blood-to-brain uptake systems for the delivery of drugs.
The company will be flexible, open-minded and collaborative in developing treatments for devastating brain disorders by combining existing drugs with proprietary drug targeting technologies.
|
|
LATEST NEWS:
- Dutch biotech company to-BBB and Taiwanese ITRI sign exclusive license agreement
- to-BBB to present at BIO-Europe 2008, November 17-19, Mannheim, Germany
- to-BBB to present at GCTBio's CNS Diseases Partnering & Deal-Making Summit, December 1-2, 2008, Boston, USA.
|
FACT SHEET:
Download our fact sheet.
(photo: Aad van Vliet / TwoMoves)
|
